NCT07494513 (MilieuTeach-AV) is a NA clinical trial of Milieu Teaching-AV in Autism, sponsored by Father Flanagan's Boys' Home.

Who is sponsoring NCT07494513?

NCT07494513 is sponsored by Father Flanagan's Boys' Home.

What drugs are being tested in NCT07494513?

Interventions in NCT07494513: Milieu Teaching-AV, Milieu Teaching-NoAV.

What condition does NCT07494513 study?

NCT07494513 studies Autism, Autism Spectrum Disorder, Autism, Susceptibility to, 6.

Is NCT07494513 still recruiting?

NCT07494513 is currently not yet recruiting. Last updated 20 March 2026.

Last reviewed 2026-03-20 · How we verify

NCT07494513: MilieuTeach-AV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Milieu Teaching-AV: A Study to Assess an Adaptation of Milieu Teaching for Infant Siblings of Autistic Children That Encourages Looking to the Mouth

Not yet recruiting NA Last updated 20 March 2026

What this trial tests

NA trial testing Milieu Teaching-AV in Autism in 60 participants. Not yet recruiting.

Timeline

1 April 2026

Primary endpoint
1 February 2029

1 February 2029

Quick facts

Lead sponsor	Father Flanagan's Boys' Home
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 April 2026
Primary completion	1 February 2029
Estimated completion	1 February 2029
Sites	1 location across United States

Drugs / interventions tested

Milieu Teaching-AV
Milieu Teaching-NoAV

Conditions studied

Autism — all drugs for Autism →
Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Autism, Susceptibility to, 6 — all drugs for Autism, Susceptibility to, 6 →

Sponsor

Father Flanagan's Boys' Home

Who can join

Adults 5 Months to 13 Months, any sex, with Autism or Autism Spectrum Disorder. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Looking to the mouth of their caregiver
Time frame: Baseline, following 3 months of intervention (i.e., post-test), and 6-month follow-up
The total number of looks to infants' caregivers' mouths during caregiver-child free play
Looking to the mouth of a speaker
Time frame: Baseline, following 3 months of intervention (i.e., post-test), and 6-month follow-up
Proportion of total looking time to mouth for native, infant-directed audiovisual speech during an eye tracking task

Sponsor's own description

This project will look at Milieu Teaching (i.e., a language intervention) that encourages looking to audiovisual speech cues (Milieu Teaching-AV) for infants with autistic older siblings (Baby Sibs), who are highly likely be diagnosed with autism or developmental language disorder (DLD), compared to Milieu Teaching alone (Milieu Teaching-NoAV). This study will specifically look at whether Milieu Teaching-AV (compared to Milieu Teaching-NoAV) results in (a) increased looking towards caregivers' faces, (b) increased communicative behaviors and language skill, and (c) increased engagement with the caregiver during play. We will also look at caregiver factors, such as their use of strategies and their attitudes toward the intervention they received.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Milieu Teaching-AV

Trials testing the same drug.

NCT06794476 — Milieu Teaching-AV (MT-AV Pilot) · NA · withdrawn

Other recruiting trials for Autism

Currently open trials in the same condition.

NCT07367256 — Using Virtual Reality to Improve Emotion Understanding in Children With Autism · NA · recruiting
NCT06853665 — The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine · Phase 4 · recruiting
NCT06523387 — Online Pivotal Response Treatment Training in Autism Spectrum Disorder · NA · recruiting
NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting

Other Father Flanagan's Boys' Home trials

Trials by the same sponsor.

NCT06794476 — Milieu Teaching-AV (MT-AV Pilot) · NA · withdrawn
NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
NCT05815537 — Development of Functional Spatial Hearing in Reverberation · EARLY_PHASE1 · completed
NCT04558541 — A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production · NA · recruiting
NCT05486637 — Vocal Emotion Communication With Cochlear Implants · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07494513 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Father Flanagan's Boys' Home
Last refreshed: 20 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07494513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing